Literature DB >> 18675830

Calcium modulation of 5-HT3 receptor binding and function.

Andrew J Thompson1, Sarah C R Lummis.   

Abstract

Calcium modulates the 5-HT3 receptor response by reducing peak current amplitude and increasing rates of activation, deactivation and desensitisation, but the binding site(s) and mechanism(s) of this modulation are unknown. Here we study residues that may be involved in calcium binding in two partially overlapping regions of the extracellular domain (E213-E215-E218 and D204-E218-V219). The modulatory effects of calcium were assessed by radioligand binding and whole-cell patch-clamp. Comparisons of [3H]granisetron binding showed an increase in Kd in 10mM calcium that was abolished by the substitutions E213Q, E215Q, D204N and V219L. E218Q mutant receptors displayed no specific binding or function, and immunofluorescence showed that they did not reach the cell surface. E213Q increased inherent rates of desensitisation, but the relative effects of calcium on these rates, and on the reduction in current amplitude, were similar to wild type receptors. Current responses and calcium-mediated effects at E215Q mutant receptors were indistinguishable from wild type. D204N and V219L mutants were non-functional. A calcium impermeable mutant (E277A/S297R) revealed no changes in peak amplitude or kinetics with increased calcium. Our results are consistent with residues D204, E218 and V219 participating in receptor assembly, structure and/or trafficking to the plasma membrane, and we speculate that this might rely upon the stabilising effect of bound calcium. E213, E215, D204 and V219 may contribute to a calcium binding site that is responsible for the calcium-mediated effects on ligand binding. However, the major site for calcium-dependent modulation of the 5-HT3 current is located within the ion channel or cell interior.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18675830      PMCID: PMC2649430          DOI: 10.1016/j.neuropharm.2008.07.009

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  35 in total

1.  Antibodies against the extracellular domain of the 5-HT3 receptor label both native and recombinant receptors.

Authors:  A D Spier; G Wotherspoon; S V Nayak; R A Nichols; J V Priestley; S C Lummis
Journal:  Brain Res Mol Brain Res       Date:  1999-04-20

2.  Low-affinity Ca(2+) and Ba(2+) binding sites in the pore of alpha7 nicotinic acetylcholine receptors.

Authors:  L K Lyford; J W Lee; R L Rosenberg
Journal:  Biochim Biophys Acta       Date:  2002-02-10

3.  The primer generator: a program that facilitates the selection of oligonucleotides for site-directed mutagenesis.

Authors:  A Turchin; J F Lawler
Journal:  Biotechniques       Date:  1999-04       Impact factor: 1.993

4.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

5.  Mutagenesis and molecular modeling reveal the importance of the 5-HT3 receptor F-loop.

Authors:  Andrew J Thompson; Claire L Padgett; Sarah C R Lummis
Journal:  J Biol Chem       Date:  2006-04-04       Impact factor: 5.157

6.  Structural determinants of Ca2+ permeability and conduction in the human 5-hydroxytryptamine type 3A receptor.

Authors:  Matthew R Livesey; Michelle A Cooper; Tarek Z Deeb; Jane E Carland; Janna Kozuska; Tim G Hales; Jeremy J Lambert; John A Peters
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

7.  Zn(2+) enhancement of the recombinant 5-HT(3) receptor is modulated by divalent cations.

Authors:  P C Hubbard; S C Lummis
Journal:  Eur J Pharmacol       Date:  2000-04-14       Impact factor: 4.432

8.  Role of aspartate 298 in mouse 5-HT3A receptor gating and modulation by extracellular Ca2+.

Authors:  Xiang-Qun Hu; David M Lovinger
Journal:  J Physiol       Date:  2005-08-11       Impact factor: 5.182

9.  The role of the agonist binding site in Ca(2+) inhibition of the recombinant 5-HT(3A) receptor.

Authors:  M I Niemeyer; S C Lummis
Journal:  Eur J Pharmacol       Date:  2001-10-05       Impact factor: 4.432

10.  Role of the outer beta-sheet in divalent cation modulation of alpha7 nicotinic receptors.

Authors:  James T McLaughlin; Jie Fu; Adrian D Sproul; Robert L Rosenberg
Journal:  Mol Pharmacol       Date:  2006-03-13       Impact factor: 4.436

View more
  2 in total

1.  Inhibition of the prokaryotic pentameric ligand-gated ion channel ELIC by divalent cations.

Authors:  Iwan Zimmermann; Alessandro Marabelli; Carlo Bertozzi; Lucia G Sivilotti; Raimund Dutzler
Journal:  PLoS Biol       Date:  2012-11-20       Impact factor: 8.029

Review 2.  Neuroregulatory role of ginkgolides.

Authors:  Martyna Gachowska; Wojciech Szlasa; Jolanta Saczko; Julita Kulbacka
Journal:  Mol Biol Rep       Date:  2021-07-10       Impact factor: 2.316

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.